Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Considerations for Interactions of Drugs Used for the Treatment of Covid-19 With Anti-Cancer Treatments Publisher Pubmed



Jafari A1 ; Dadkhahfar S2 ; Perseh S3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Radiation Oncology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  2. 2. Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  3. 3. School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

Source: Critical Reviews in Oncology/Hematology Published:2020


Abstract

SARS-CoV2 infection is an emerging issue worldwide. Cancer patient are at increased risk of infection compared to general population. On the other hand, these patients are at major risk of drug interactions caused by renal and hepatic impairment background. Because of the long-term use of chemotherapy drugs, drug interactions are important in these patients especially with SARS-CoV2 treatments now. This paper is review of reported drug interactions of current treatments for COVID-19 and anticancer agents. © 2020 Elsevier B.V.
Related Docs
View other Related Docs
1. Pharmacological Treatments of Covid-19, Pharmacological Reports (2020)
2. Avermectin, Encyclopedia of Toxicology# Fourth Edition: Volume 1-9 (2023)
3. The Situation of Small Molecules Targeting Key Proteins in Combatting Sars-Cov-2: Synthesis, Metabolic Pathway, Mechanism of Action, and Potential Therapeutic Applications, Mini-Reviews in Medicinal Chemistry (2022)
4. Can Anti-Parasitic Drugs Help Control Covid-19?, Future Virology (2022)
5. Covid-19: Transmission, Prevention, and Potential Therapeutic Opportunities, Clinica Chimica Acta (2020)
6. Safety and Efficacy of Remdesivir for the Treatment of Covid-19: A Rapid Review of Available Evidence, Health Technology Assessment in Action (2020)
7. Remdesivir: A Beacon of Hope From Ebola Virus Disease to Covid-19, Reviews in Medical Virology (2020)
8. Existing Antiviral Options Against Sars-Cov-2 Replication in Covid-19 Patients, Future Microbiology (2020)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (5)
Mohammad Sharifzadeh (1)
Other Related Docs
9. Targeting the Vital Non-Structural Proteins (Nsp12, Nsp7, Nsp8 and Nsp3) From Sars-Cov-2 and Inhibition of Rna Polymerase by Natural Bioactive Compound Naringenin As a Promising Drug Candidate Against Covid-19, Journal of Molecular Structure (2023)
10. Covid-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods, Anti-Cancer Agents in Medicinal Chemistry (2021)
11. Current Treatments and Therapeutic Options for Covid-19 Patients: A Systematic Review, Infectious Disorders - Drug Targets (2022)
12. Prevention of Covid-19: Preventive Strategies for General Population, Healthcare Setting, and Various Professions, Advances in Experimental Medicine and Biology (2021)
13. Novel Therapeutic Approaches for Treatment of Covid-19, Journal of Molecular Medicine (2020)
14. Sars-Cov-2: Current Trends in Emerging Variants, Pathogenesis, Immune Responses, Potential Therapeutic, and Vaccine Development Strategies, International Immunopharmacology (2021)
15. Application of Chloroquine As an Endosomal Escape Enhancing Agent: New Frontiers for an Old Drug, Expert Opinion on Drug Delivery (2021)
16. A Review of Covid-19: The Main Ways of Transmission and Some Prevention Solutions, Clinical Symptoms, More Vulnerable Human Groups, Risk Factors, Diagnosis, and Treatment, Journal of Environmental Treatment Techniques (2020)
17. The Immune System As a Target for Therapy of Sars-Cov-2: A Systematic Review of the Current Immunotherapies for Covid-19, Life Sciences (2020)
18. Sars-Cov-2: From the Pathogenesis to Potential Anti-Viral Treatments, Biomedicine and Pharmacotherapy (2021)
19. Covid-19: A Systematic Review and Update on Prevention, Diagnosis, and Treatment, MedComm (2022)